Improving the in vivo bioavailability and in vitro anti-inflammatory activity of tanshinone IIA by alginate solid dispersion

Childs, 2013, Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability, Mol. Pharm., 10, 3112, 10.1021/mp400176y Zhao, 2020, Polysaccharide from vinegar baked radix bupleuri as efficient solubilizer for water-insoluble drugs of Chinese medicine, Carbohydr. Polym., 229, 115473, 10.1016/j.carbpol.2019.115473 Han, 2019, Predicting physical stability of solid dispersions by machine learning techniques, J. Contr. Release, 311–312, 16, 10.1016/j.jconrel.2019.08.030 Jain, 2015, Solubility and dissolution enhancement strategies: current understanding and recent trends, Drug Dev. Ind. Pharm., 41, 875, 10.3109/03639045.2014.971027 Nie, 2015, Investigating the interaction pattern and structural elements of a drug-polymer complex at the molecular level, Mol. Pharm., 12, 2459, 10.1021/acs.molpharmaceut.5b00162 Lee, 2005, Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability, Arch Pharm. Res. (Seoul), 28, 866, 10.1007/BF02977355 Vasconcelos, 2016, Amorphous solid dispersions: rational selection of a manufacturing process, Adv. Drug Deliv. Rev., 100, 85, 10.1016/j.addr.2016.01.012 Leuner, 2000, Improving drug solubility for oral delivery using solid dispersions, Eur. J. Pharm. Biopharm., 50, 47, 10.1016/S0939-6411(00)00076-X Janssens, 2009, Review: physical chemistry of solid dispersions, J. Pharm. Pharmacol., 61, 1571, 10.1211/jpp.61.12.0001 Zerrouk, 2001, In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions, Int. J. Pharm., 225, 49, 10.1016/S0378-5173(01)00741-4 Eloy, 2014, Solid dispersions containing ursolic acid in Poloxamer 407 and PEG 6000: a comparative study of fusion and solvent methods, Powder Technol., 253, 98, 10.1016/j.powtec.2013.11.017 Jahangiri, 2015, Pharmacological and histological examination of atorvastatin-PVP K30 solid dispersions, Powder Technol., 286, 538, 10.1016/j.powtec.2015.08.047 Otto, 2013, Experimental and mesoscale computational dynamics studies of the relationship between solubility and release of quercetin from PEG solid dispersions, Int. J. Pharm., 456, 282, 10.1016/j.ijpharm.2013.08.039 Borba, 2016, Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs, Carbohydr. Polym., 137, 350, 10.1016/j.carbpol.2015.10.070 Elmowafy, 2019, Losartan-chitosan/dextran sulfate microplex as a carrier to lung therapeutics: dry powder inhalation, aerodynamic profile and pulmonary tolerability, Int. J. Biol. Macromol., 136, 220, 10.1016/j.ijbiomac.2019.06.058 Li, 2013, Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices, Carbohydr. Polym., 98, 1108, 10.1016/j.carbpol.2013.07.017 Lee, 2012, Alginate: properties and biomedical applications, Prog. Polym. Sci., 37, 106, 10.1016/j.progpolymsci.2011.06.003 George, 2006, Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review, J. Contr. Release, 114, 1, 10.1016/j.jconrel.2006.04.017 Pawar, 2012, Alginate derivatization: a review of chemistry, properties and applications, Biomaterials, 33, 3279, 10.1016/j.biomaterials.2012.01.007 Josef, 2010, Composite alginate hydrogels: an innovative approach for the controlled release of hydrophobic drugs, Acta Biomater., 6, 4642, 10.1016/j.actbio.2010.06.032 Manatunga, 2017, pH responsive controlled release of anti-cancer hydrophobic drugs from sodium alginate and hydroxyapatite bi-coated iron oxide nanoparticles, Eur. J. Pharm. Biopharm., 117, 29, 10.1016/j.ejpb.2017.03.014 Guan, 2018, Alginate as a potential diphase solid dispersion carrier with enhanced drug dissolution and improved storage stability, Eur. J. Pharmaceut. Sci., 114, 346, 10.1016/j.ejps.2017.12.028 Guan, 2020, Elucidation of alginate-drug miscibility on its crystal growth inhibition effect in supersaturated drug delivery system, Carbohydr. Polym., 230, 115601, 10.1016/j.carbpol.2019.115601 Gao, 2012, Cardiovascular actions and therapeutic potential of tanshinone IIA, Atherosclerosis, 220, 3, 10.1016/j.atherosclerosis.2011.06.041 Guan, 2018, Sodium tanshinone IIA sulfonate decreases cigarette smoke-induced inflammation and oxidative stress via blocking the activation of MAPK/HIF-1α signaling pathway, Front. Pharmacol., 9, 263, 10.3389/fphar.2018.00263 Jiang, 2016, Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axis, Am. J. Physiol. Cell Physiol., 311, C136, 10.1152/ajpcell.00252.2015 Zhou, 2019, Sodium tanshinone IIA sulfonate: a review of pharmacological activity and pharmacokinetics, Biomed. Pharmacother., 118, 109362, 10.1016/j.biopha.2019.109362 Yan, 2015, Tanshinone IIA - loaded pellets developed for angina chronotherapy: deconvolution-based formulation design and optimization, pharmacokinetic and pharmacodynamic evaluation, Eur. J. Pharmaceut. Sci., 76, 156, 10.1016/j.ejps.2015.05.012 Zhang, 2013, Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins, Biomaterials, 34, 306, 10.1016/j.biomaterials.2012.09.058 Chu, 2012, Development of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity in vitro, Int. J. Pharm., 424, 76, 10.1016/j.ijpharm.2011.12.049 Liu, 2013, The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia, Biomaterials, 34, 6893, 10.1016/j.biomaterials.2013.05.021 Mao, 2018, Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway, Artif Cells Nanomed Biotechnol, 46, S707, 10.1080/21691401.2018.1508028 Zhang, 2014, TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy, Int. J. Pharm., 476, 185 Zhai, 2017, Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones, Asian J. Pharm. Sci., 12, 85, 10.1016/j.ajps.2016.08.004 Luo, 2019, A novel tanshinone IIA/chitosan solid dispersion: preparation, characterization and cytotoxicity evaluation, J. Drug Deliv. Sci. Technol., 49, 260, 10.1016/j.jddst.2018.11.024 Luo, 2019, Preparation and drug release property of tanshinone IIA loaded chitosan-montmorillonite microspheres, Int. J. Biol. Macromol., 125, 721, 10.1016/j.ijbiomac.2018.12.072 Li, 2012, Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluation, Eur. J. Pharm. Biopharm., 80, 426, 10.1016/j.ejpb.2011.11.003 Zhang, 2010, PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel, Comput. Methods Progr. Biomed., 99, 306, 10.1016/j.cmpb.2010.01.007 Patil, 2015, Apigenin inhibits PMA-induced expression of pro-inflammatory cytokines and AP-1 factors in A549 cells, Mol. Cell. Biochem., 403, 95, 10.1007/s11010-015-2340-3 Baghel, 2016, Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs, J. Pharmacol. Sci., 105, 2527, 10.1016/j.xphs.2015.10.008 Wang, 2017, Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify, Eur. J. Pharmaceut. Sci., 96, 45, 10.1016/j.ejps.2016.08.046 Herbrink, 2017, Improving the solubility of nilotinib through novel spray-dried solid dispersions, Int. J. Pharm., 529, 294, 10.1016/j.ijpharm.2017.07.010 Vaziri, 2018, Co-microencapsulation of Lactobacillus plantarum and DHA fatty acid in alginate-pectin-gelatin biocomposites, Carbohydr. Polym., 199, 266, 10.1016/j.carbpol.2018.07.002 Meng, 2015, Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles, Eur. J. Pharmaceut. Sci., 73, 35, 10.1016/j.ejps.2015.03.002 Van den Mooter, 2006, Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs, Int. J. Pharm., 316, 1, 10.1016/j.ijpharm.2006.02.025 Liu, 2018, Tanshinone IIA ameliorates lipopolysaccharide-induced inflammatory response in bronchial epithelium cell line BEAS-2B by down-regulating miR-27a, Biomed. Pharmacother., 104, 158, 10.1016/j.biopha.2018.05.021 Moon, 2011, ROS/Epac1-mediated Rap 1/NF-kappaB activation is required for the expression of BAFF in Raw264.7 murine macrophages, Cell. Signal., 23, 1479, 10.1016/j.cellsig.2011.05.001 Deng, 2017, Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-κB pathway, Biomed. Pharmacother., 96, 148, 10.1016/j.biopha.2017.09.094